Clinical study offer

🩸 Paid Leukemia Clinical Trials

Browse recruiting leukemia clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Leukemia
Condition

Active Clinical Trials for Leukemia

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Leukemia

Leukemia is a cancer of blood-forming tissues including bone marrow and lymphatic system, causing abnormal white blood cell production. Clinical trials investigate targeted therapies, immunotherapies including CAR T-cell therapy, and combination treatment approaches.

Common Symptoms

Fatigue, frequent infections, fever, easy bruising or bleeding, weight loss, swollen lymph nodes, bone pain, night sweats, shortness of breath

Risk Factors

Age, smoking, family history, certain genetic disorders (Down syndrome), prior chemotherapy or radiation, exposure to benzene, certain blood disorders (MDS)

Treatment Overview

Treatment includes chemotherapy, targeted therapy (tyrosine kinase inhibitors, FLT3 inhibitors), immunotherapy (CAR T-cells, bispecific antibodies), and stem cell transplantation. Clinical trials explore novel targeted agents, allogeneic CAR T-cells, and combination immunotherapy strategies.

Why Participate?

Leukemia clinical trials offer access to groundbreaking immunotherapies and targeted treatments that are transforming survival rates for blood cancers.

Related Conditions

States with Leukemia Clinical Trials

Cities with Leukemia Clinical Trials

Frequently Asked Questions About Leukemia Clinical Trials

Leukemia clinical trials test new chemotherapy combinations, targeted therapies, and immunotherapies including CAR T-cell therapy to treat blood cancers. Studies focus on improving remission rates and reducing treatment toxicity.
Eligibility depends on leukemia type (AML, ALL, CLL, CML), genetic markers, disease stage, prior treatments, and overall health status.
Compensation varies by study. Many trials focus on treatment access and may provide travel reimbursement plus a stipend of $50-$100 per visit.
Yes, participants receive close monitoring from oncology teams. All trials have safety committees and access to standard treatments is maintained.